Concepedia

Author

F Zintl

Friedrich Schiller University Jena

Also Known As

F ZINTL, F Zintl, F. Zintl, F.  Zintl, FELIX ZINTL, Felix Zintl, The former Working Group Pediatric Hematology and Oncology, Zintl F, Zintl, F

288

Publications

7K

Citations

46

H-Index

114

Concepts

All Affiliations

Friedrich Schiller University JenaJena University HospitalHeidelberg UniversityMedizinische Hochschule HannoverGerman Cancer Research Center
FZ

About

F Zintl is an author at Friedrich Schiller University Jena specializing in medicine, hematology, and immunology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

30

48

2.7K

2

Health Sciences

13

13

929

3

Engineering

2

2

72

4

Public Health

2

2

62

5

Natural Sciences

1

1

68

F Zintl

×

83

Publications

6.4K

Citations

45

H-Index

YearCitations

Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. German-Austrian-Swiss ALL-BFM Study Group.

Martin Schrappe, Alfred Reiter, Wolfgang Ludwig,

PubMed

2000

609

Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95

Anja Möricke, Alfred Reiter, Martin Zimmermann,

Blood

2008

601

Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000

Anja Möricke, M Zimmermann, Alfred Reiter,

Leukemia

2009

520

Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90.

Alfred Reiter, Martin Schrappe, Markus Tiemann,

PubMed

1999

404

BCRP gene expression is associated with a poor response to remission induction therapy in childhood acute myeloid leukemia

Daniel Steinbach, Wieland Sell, Astrid Voigt,

Leukemia

2002

224

Autologous stem cell transplantation for systemic lupus erythematosus

David Jayne, Jakob Passweg, A Marmont,

Lupus

2004

183

Prediction of Broad Spectrum Resistance of Tumors towards Anticancer Drugs

Thomas Efferth, V. Badireenath Konkimalla, Yi‐Fen Wang,

Clinical Cancer Research

2008

166

Identification of a Set of Seven Genes for the Monitoring of Minimal Residual Disease in Pediatric Acute Myeloid Leukemia

Daniel Steinbach, Alexander Schramm, Angelika Eggert,

Clinical Cancer Research

2006

131

ABCA3 as a Possible Cause of Drug Resistance in Childhood Acute Myeloid Leukemia

Daniel Steinbach, Jean‐Pierre Gillet, Axel Sauerbrey,

Clinical Cancer Research

2006

121

CNS late effects after ALL therapy in childhood. Part I: Neuroradiological findings in long-term survivors of childhood ALL—an evaluation of the interferences between morphology and neuropsychological performance

Holger Hertzberg, W. Huk, Michael A. Ueberall,

Medical and Pediatric Oncology

1997

114

Page 1